SAM
TECH icon

Strategy Asset Managers’s Bio-Techne TECH Stock Holding History

Strategy Asset Managers’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,420
Closed -$643K – 281
2022
Q2 		$643K Sell
7,420
-80
-1% -$7.5K 0.2% 90
2022
Q1 		$812K Buy
+7,500
New +$774K 0.18% 99

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Strategy Asset Managers's TECH Position: Q3 2022 in Review

Strategy Asset Managers sold out of Bio-Techne (TECH) in Q3 2022, closing a stake of 7,420 shares — an estimated $643K sold.

Strategy Asset Managers first reported a position in TECH in Q1 2022 and held it in 2 quarters. The position peaked at $812K in Q1 2022. 536 funds tracked by Wall St. Rank hold TECH as of Q3 2022.

  • Strategy Asset Managers reported no remaining Bio-Techne position as of Q3 2022 after selling out during the quarter.
  • Strategy Asset Managers sold 7,420 Bio-Techne shares in Q3 2022, an estimated $643K.
  • Strategy Asset Managers first reported a position in Bio-Techne in Q1 2022 and held it in 2 quarters.
  • Strategy Asset Managers's Bio-Techne position peaked at $812K in Q1 2022.
  • 536 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2022.

Based on Strategy Asset Managers's 13F filing for Q3 2022, filed 11 Oct 2022.